Clinical Trial Detail

NCT ID NCT03744793
Title Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

transitional cell carcinoma

Therapies

Avelumab + Pemetrexed Disodium

Age Groups: adult senior

No variant requirements are available.